Lung cancer drug delay slammed as nivolumab is pulled from early access scheme

… , chief executive of Roy Castle Lung Cancer Foundation, said patients are unlikely … shift in the treatment of lung cancer''. Researchers compared the … lung cancer. The disease accounts for around 85% of all cases of lung cancer … specific group of people with lung cancer and offers hope where there …